Shopping Cart
- Remove All
- Your shopping cart is currently empty
UP202-56 is an adenosinergic agonist and is an adenosine analog.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 6-8 weeks | |
50 mg | 2.071 € | 6-8 weeks | |
100 mg | 2.660 € | 6-8 weeks |
Description | UP202-56 is an adenosinergic agonist and is an adenosine analog. |
In vitro | UP202-56(oral administration) are assessed on carrageenan-induced spinal c-Fos protein expression and peripheral oedema. Oral UP202-56 (10, 30 or 50 mg/kg) dose-dependently reduces the number of carrageenan-induced c-Fos like immunoreactivity (c-Fos-LI) neurons (r=0.931. P<0.0001), with the highest dose of UP202-56 producing 72±4% reduction of the total number of carrageenan-induced spinal c-Fos-LI neurons, and 12±3% and 33±6% of reduction of control carrageenan oedema at paw and ankle levels, respectively.UP202-56 dose-dependently reduced the expression of spinal cord c-Fos protein in carrageenan inflammatory pain model [1]. UP202-56 is an adenosine agonist[2]. |
Molecular Weight | 595.69 |
Formula | C33H37N7O4 |
Cas No. | 163838-04-8 |
Relative Density. | 1.47 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.